Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model
- PMID: 22872421
- DOI: 10.1007/s12194-012-0172-3
Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model
Abstract
This study aimed to identify the optimal concentration, injection rate, and total volume of contrast medium (CM) for evaluating the hemodynamics of a hepatocellular carcinoma (HCC) structure model of diameter 35 mm, using multi-level dynamic computed tomography (M-LDCT) with 64 detector rows. A tube was inserted in the model as a simulated vessel. Five CM concentrations were used: non-diluted, 2-, 3-, 6-, and 9-fold diluted. Five regions of interest were placed within the HCC structure model. Time-density curves were created for CM injection rates of 1, 2, and 3 ml/s for 10 s, and for a total volume of 10 ml, followed by saline injection at 1 ml/s. M-LDCT maximum intensity projection images were evaluated by four appraisers using a three-point scale (excellent, 2; good, 1; poor, 0). There was no significant difference between maximum CT values at 2 ml/s for 10 s and those at 3 ml/s; these values were both greater than those at 1 ml/s. The duration of the peak was maintained for longer at 3 ml/s for 10 s (5.2 ± 2.3 s) than at 2 ml/s (3.6 ± 0.9 s). Maximum CT values at 2 ml/s of a total volume of 10 ml were greater than those at 3 ml/s. The highest scores of 7 and 8 were found at 2 and 3 ml/s for 10 s, using 2-, 3-, or 6-fold diluted CM. The most appropriate CM rate for evaluating hemodynamics was 2 ml/s for 10 s, using 2-, 3-, or 6-fold diluted CM.
Similar articles
-
Intra- and perinodular hemodynamics of hepatocellular carcinoma: CT observation during intra-arterial contrast injection.Abdom Imaging. 2002 Mar-Apr;27(2):147-56. doi: 10.1007/s00261-001-0091-y. Abdom Imaging. 2002. PMID: 11847574 Review. No abstract available.
-
Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.AJR Am J Roentgenol. 2008 Sep;191(3):772-7. doi: 10.2214/AJR.07.3452. AJR Am J Roentgenol. 2008. PMID: 18716108
-
Preliminary study: color map of hepatocellular carcinoma using dynamic contrast-enhanced 256-detector row CT.Eur J Radiol. 2007 May;62(2):308-10. doi: 10.1016/j.ejrad.2006.11.036. Epub 2006 Dec 28. Eur J Radiol. 2007. PMID: 17196353
-
Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.J Nucl Med. 2013 Jun;54(6):848-54. doi: 10.2967/jnumed.112.113936. Epub 2013 Mar 25. J Nucl Med. 2013. PMID: 23528383
-
Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.Oncology. 2011;81 Suppl 1:86-99. doi: 10.1159/000333267. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212941 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical